|Bid||102.54 x 900|
|Ask||106.25 x 800|
|Day's range||102.31 - 104.43|
|52-week range||86.71 - 161.37|
|Beta (5Y monthly)||1.30|
|PE ratio (TTM)||5.79|
|Earnings date||26 Apr 2023 - 01 May 2023|
|Forward dividend & yield||2.80 (2.33%)|
|Ex-dividend date||17 Feb 2023|
|1y target est||123.79|
Celanese (CE) forms an alliance with Alessa Therapeutics to develop an innovative drug delivery system for oncology patients.
The oracle of Omaha's focus on buying great businesses shines through in these three stock picks.
Celanese (CE) joins forces with Mitsui to form a new Food Ingredient joint venture to strengthen its strategic partnership with the latter.